カテゴリー： QYResearch, 世界, 医療/バイオ

ウェアラブルボーラスインジェクターのグローバル市場2023年：電子インジェクター、メカニカルインジェクター

◆英語タイトル：Global Wearable Bolus Injectors Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA8511）◆商品コード：QYR23MA8511
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：91
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のウェアラブルボーラスインジェクター市場について調査・分析し、世界のウェアラブルボーラスインジェクター市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（電子インジェクター、メカニカルインジェクター）、用途別セグメント分析（がん治療、自己免疫治療、血液疾患治療、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、West Pharmaceuticals、Ypsomed、BD、CeQur、Gerresheimer AG、Amgen、Enable Injections、United Therapeutics、E3D Elcam Drug Delivery Devices、Eitan Medical、Sonceboz、CCbio、KORU Medical Systems、Subcujectなどが含まれています。世界のウェアラブルボーラスインジェクター市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ウェアラブルボーラスインジェクター市場規模を推定する際に考慮しました。

・ウェアラブルボーラスインジェクター市場の概要
- 製品の定義
- ウェアラブルボーラスインジェクターのタイプ別セグメント
- 世界のウェアラブルボーラスインジェクター市場規模：タイプ別分析（電子インジェクター、メカニカルインジェクター）
- ウェアラブルボーラスインジェクターの用途別セグメント
- 世界のウェアラブルボーラスインジェクター市場規模：用途別分析（がん治療、自己免疫治療、血液疾患治療、その他）
- 世界のウェアラブルボーラスインジェクター市場規模予測（2018年-2029年）
- ウェアラブルボーラスインジェクターの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ウェアラブルボーラスインジェクター市場の競争状況およびトレンド

・ウェアラブルボーラスインジェクターの地域別市場規模
- 北米のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- アメリカのウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- ヨーロッパのウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- アジア太平洋のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- 中国のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- 日本のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- 韓国のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- インドのウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- オーストラリアのウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- 中南米のウェアラブルボーラスインジェクター市場規模（2018年-2029年）
- 中東・アフリカのウェアラブルボーラスインジェクター市場規模（2018年-2029年）

・タイプ別セグメント：電子インジェクター、メカニカルインジェクター
- 世界のウェアラブルボーラスインジェクターのタイプ別販売量（2018年-2023年）
- 世界のウェアラブルボーラスインジェクターのタイプ別売上（2018年-2023年）
- 世界のウェアラブルボーラスインジェクターのタイプ別価格

・用途別セグメント：がん治療、自己免疫治療、血液疾患治療、その他
- 世界のウェアラブルボーラスインジェクターの用途別販売量（2018年-2023年）
- 世界のウェアラブルボーラスインジェクターの用途別売上（2018年-2023年）
- 世界のウェアラブルボーラスインジェクターの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
West Pharmaceuticals、Ypsomed、BD、CeQur、Gerresheimer AG、Amgen、Enable Injections、United Therapeutics、E3D Elcam Drug Delivery Devices、Eitan Medical、Sonceboz、CCbio、KORU Medical Systems、Subcuject

・産業チェーンと販売チャネルの分析
- ウェアラブルボーラスインジェクター産業チェーン分析
- ウェアラブルボーラスインジェクターの主要原材料
- ウェアラブルボーラスインジェクターの販売チャネル
- ウェアラブルボーラスインジェクターのディストリビューター
- ウェアラブルボーラスインジェクターの主要顧客

・ウェアラブルボーラスインジェクター市場ダイナミクス
- ウェアラブルボーラスインジェクターの業界動向
- ウェアラブルボーラスインジェクター市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Bolus injectors are wearable injectors that have the capability to deliver more than 1 ml of a drug subcutaneously in a simple, reliable, and inexpensive manner. Bolus injectors allow patients to easily and comfortably self-administer injectable drugs. In addition, drug delivery with bolus injectors may enable additional treatment advances by making it possible to safely, conveniently, and cost effectively deliver many of the more than 900 biologics and biosimilars in development today.
Highlights
The global Wearable Bolus Injectors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Wearable Bolus Injectors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Wearable Bolus Injectors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Wearable Bolus Injectors include West Pharmaceuticals, Ypsomed, BD, CeQur, Gerresheimer AG, Amgen, Enable Injections, United Therapeutics and E3D Elcam Drug Delivery Devices, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Bolus Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Bolus Injectors.
The Wearable Bolus Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Wearable Bolus Injectors market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Bolus Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
West Pharmaceuticals
Ypsomed
BD
CeQur
Gerresheimer AG
Amgen
Enable Injections
United Therapeutics
E3D Elcam Drug Delivery Devices
Eitan Medical
Sonceboz
CCbio
KORU Medical Systems
Subcuject
Segment by Type
Electronical Injectors
Mechanical Injectors
Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Bolus Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Bolus Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Wearable Bolus Injectors Market Overview
1.1 Product Overview and Scope of Wearable Bolus Injectors
1.2 Wearable Bolus Injectors Segment by Type
1.2.1 Global Wearable Bolus Injectors Market Value Comparison by Type (2023-2029)
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.3 Wearable Bolus Injectors Segment by Application
1.3.1 Global Wearable Bolus Injectors Market Value by Application: (2023-2029)
1.3.2 Cancer Treatment
1.3.3 Auto-immune Treatment
1.3.4 Blood Disorders Treatment
1.3.5 Others
1.4 Global Wearable Bolus Injectors Market Size Estimates and Forecasts
1.4.1 Global Wearable Bolus Injectors Revenue 2018-2029
1.4.2 Global Wearable Bolus Injectors Sales 2018-2029
1.4.3 Global Wearable Bolus Injectors Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Wearable Bolus Injectors Market Competition by Manufacturers
2.1 Global Wearable Bolus Injectors Sales Market Share by Manufacturers (2018-2023)
2.2 Global Wearable Bolus Injectors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Wearable Bolus Injectors Average Price by Manufacturers (2018-2023)
2.4 Global Wearable Bolus Injectors Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Wearable Bolus Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Bolus Injectors, Product Type & Application
2.7 Wearable Bolus Injectors Market Competitive Situation and Trends
2.7.1 Wearable Bolus Injectors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Wearable Bolus Injectors Players Market Share by Revenue
2.7.3 Global Wearable Bolus Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Wearable Bolus Injectors Retrospective Market Scenario by Region
3.1 Global Wearable Bolus Injectors Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Wearable Bolus Injectors Global Wearable Bolus Injectors Sales by Region: 2018-2029
3.2.1 Global Wearable Bolus Injectors Sales by Region: 2018-2023
3.2.2 Global Wearable Bolus Injectors Sales by Region: 2024-2029
3.3 Global Wearable Bolus Injectors Global Wearable Bolus Injectors Revenue by Region: 2018-2029
3.3.1 Global Wearable Bolus Injectors Revenue by Region: 2018-2023
3.3.2 Global Wearable Bolus Injectors Revenue by Region: 2024-2029
3.4 North America Wearable Bolus Injectors Market Facts & Figures by Country
3.4.1 North America Wearable Bolus Injectors Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Wearable Bolus Injectors Sales by Country (2018-2029)
3.4.3 North America Wearable Bolus Injectors Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Wearable Bolus Injectors Market Facts & Figures by Country
3.5.1 Europe Wearable Bolus Injectors Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Wearable Bolus Injectors Sales by Country (2018-2029)
3.5.3 Europe Wearable Bolus Injectors Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Bolus Injectors Market Facts & Figures by Country
3.6.1 Asia Pacific Wearable Bolus Injectors Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Wearable Bolus Injectors Sales by Country (2018-2029)
3.6.3 Asia Pacific Wearable Bolus Injectors Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Wearable Bolus Injectors Market Facts & Figures by Country
3.7.1 Latin America Wearable Bolus Injectors Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Wearable Bolus Injectors Sales by Country (2018-2029)
3.7.3 Latin America Wearable Bolus Injectors Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Bolus Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Bolus Injectors Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Wearable Bolus Injectors Sales by Country (2018-2029)
3.8.3 Middle East and Africa Wearable Bolus Injectors Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Wearable Bolus Injectors Sales by Type (2018-2029)
4.1.1 Global Wearable Bolus Injectors Sales by Type (2018-2023)
4.1.2 Global Wearable Bolus Injectors Sales by Type (2024-2029)
4.1.3 Global Wearable Bolus Injectors Sales Market Share by Type (2018-2029)
4.2 Global Wearable Bolus Injectors Revenue by Type (2018-2029)
4.2.1 Global Wearable Bolus Injectors Revenue by Type (2018-2023)
4.2.2 Global Wearable Bolus Injectors Revenue by Type (2024-2029)
4.2.3 Global Wearable Bolus Injectors Revenue Market Share by Type (2018-2029)
4.3 Global Wearable Bolus Injectors Price by Type (2018-2029)
5 Segment by Application
5.1 Global Wearable Bolus Injectors Sales by Application (2018-2029)
5.1.1 Global Wearable Bolus Injectors Sales by Application (2018-2023)
5.1.2 Global Wearable Bolus Injectors Sales by Application (2024-2029)
5.1.3 Global Wearable Bolus Injectors Sales Market Share by Application (2018-2029)
5.2 Global Wearable Bolus Injectors Revenue by Application (2018-2029)
5.2.1 Global Wearable Bolus Injectors Revenue by Application (2018-2023)
5.2.2 Global Wearable Bolus Injectors Revenue by Application (2024-2029)
5.2.3 Global Wearable Bolus Injectors Revenue Market Share by Application (2018-2029)
5.3 Global Wearable Bolus Injectors Price by Application (2018-2029)
6 Key Companies Profiled
6.1 West Pharmaceuticals
6.1.1 West Pharmaceuticals Corporation Information
6.1.2 West Pharmaceuticals Description and Business Overview
6.1.3 West Pharmaceuticals Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 West Pharmaceuticals Wearable Bolus Injectors Product Portfolio
6.1.5 West Pharmaceuticals Recent Developments/Updates
6.2 Ypsomed
6.2.1 Ypsomed Corporation Information
6.2.2 Ypsomed Description and Business Overview
6.2.3 Ypsomed Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Ypsomed Wearable Bolus Injectors Product Portfolio
6.2.5 Ypsomed Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Wearable Bolus Injectors Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 CeQur
6.4.1 CeQur Corporation Information
6.4.2 CeQur Description and Business Overview
6.4.3 CeQur Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CeQur Wearable Bolus Injectors Product Portfolio
6.4.5 CeQur Recent Developments/Updates
6.5 Gerresheimer AG
6.5.1 Gerresheimer AG Corporation Information
6.5.2 Gerresheimer AG Description and Business Overview
6.5.3 Gerresheimer AG Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gerresheimer AG Wearable Bolus Injectors Product Portfolio
6.5.5 Gerresheimer AG Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amgen Wearable Bolus Injectors Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Enable Injections
6.6.1 Enable Injections Corporation Information
6.6.2 Enable Injections Description and Business Overview
6.6.3 Enable Injections Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Enable Injections Wearable Bolus Injectors Product Portfolio
6.7.5 Enable Injections Recent Developments/Updates
6.8 United Therapeutics
6.8.1 United Therapeutics Corporation Information
6.8.2 United Therapeutics Description and Business Overview
6.8.3 United Therapeutics Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 United Therapeutics Wearable Bolus Injectors Product Portfolio
6.8.5 United Therapeutics Recent Developments/Updates
6.9 E3D Elcam Drug Delivery Devices
6.9.1 E3D Elcam Drug Delivery Devices Corporation Information
6.9.2 E3D Elcam Drug Delivery Devices Description and Business Overview
6.9.3 E3D Elcam Drug Delivery Devices Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.9.4 E3D Elcam Drug Delivery Devices Wearable Bolus Injectors Product Portfolio
6.9.5 E3D Elcam Drug Delivery Devices Recent Developments/Updates
6.10 Eitan Medical
6.10.1 Eitan Medical Corporation Information
6.10.2 Eitan Medical Description and Business Overview
6.10.3 Eitan Medical Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Eitan Medical Wearable Bolus Injectors Product Portfolio
6.10.5 Eitan Medical Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Corporation Information
6.11.2 Sonceboz Wearable Bolus Injectors Description and Business Overview
6.11.3 Sonceboz Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sonceboz Wearable Bolus Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 CCbio
6.12.1 CCbio Corporation Information
6.12.2 CCbio Wearable Bolus Injectors Description and Business Overview
6.12.3 CCbio Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CCbio Wearable Bolus Injectors Product Portfolio
6.12.5 CCbio Recent Developments/Updates
6.13 KORU Medical Systems
6.13.1 KORU Medical Systems Corporation Information
6.13.2 KORU Medical Systems Wearable Bolus Injectors Description and Business Overview
6.13.3 KORU Medical Systems Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.13.4 KORU Medical Systems Wearable Bolus Injectors Product Portfolio
6.13.5 KORU Medical Systems Recent Developments/Updates
6.14 Subcuject
6.14.1 Subcuject Corporation Information
6.14.2 Subcuject Wearable Bolus Injectors Description and Business Overview
6.14.3 Subcuject Wearable Bolus Injectors Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Subcuject Wearable Bolus Injectors Product Portfolio
6.14.5 Subcuject Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Bolus Injectors Industry Chain Analysis
7.2 Wearable Bolus Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Bolus Injectors Production Mode & Process
7.4 Wearable Bolus Injectors Sales and Marketing
7.4.1 Wearable Bolus Injectors Sales Channels
7.4.2 Wearable Bolus Injectors Distributors
7.5 Wearable Bolus Injectors Customers
8 Wearable Bolus Injectors Market Dynamics
8.1 Wearable Bolus Injectors Industry Trends
8.2 Wearable Bolus Injectors Market Drivers
8.3 Wearable Bolus Injectors Market Challenges
8.4 Wearable Bolus Injectors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ウェアラブルボーラスインジェクターのグローバル市場2023年：電子インジェクター、メカニカルインジェクター(Global Wearable Bolus Injectors Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ボーラスインジェクターの世界市場見通し2023年-2029年
  • ウェアラブルインジェクターのグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆